Morgan Ventures re-appoints Dr. Sanjiv Bansal as Independent Director

Morgan Ventures Limited has approved the re-appointment of Dr. Sanjiv Bansal as an Independent Director for a second term of five years, effective June 17, 2026. The decision, taken by the Board of Directors on May 29, 2026, is subject to the approval of the company's shareholders. This move ensures continuity in the company's governance structure as Dr. Bansal completes his first term.

The re-appointment follows the recommendation of the Nomination and Remuneration Committee. Dr. Bansal's new term will commence on June 17, 2026, and conclude on June 17, 2031. He will not be liable to retire by rotation during this period. The company disclosed these details in a filing submitted to BSE Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Dr. Sanjiv Bansal is a physician by profession, having completed his education at the University of Mysore. He brings extensive experience in diagnosing and managing a wide range of medical conditions. Beyond his medical practice, he owns Bansal Hospitals in Delhi and possesses significant management experience through directorships in various companies.

The disclosure confirms that Dr. Bansal is not related to any other director on the Board of Morgan Ventures Limited. Furthermore, he is not debarred from holding the office of director by any order of the Securities and Exchange Board of India or any other regulatory authority, as required under relevant circulars.

Details of Re-appointment

Particulars	Details
Name of the Director	Dr. Sanjiv Bansal (DIN: 00417480)
Reason for Change	Re-appointment as Independent Director (second term)
Effective Date of Appointment	June 17, 2026
Term of Appointment	Five consecutive years from June 17, 2026 to June 17, 2031
Relationship with other Directors	Not related to any director of the Company
Regulatory Status	Not debarred from holding office of director

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.06%	-1.42%	-10.88%	-33.64%	-55.33%	+314.81%

Morgan Ventures Limited has appointed H. Tara & Co., Practicing Cost Accountants, as its internal auditor for the financial year 2026-2027. The Board of Directors approved the appointment during a meeting held on May 29, 2026. The firm will oversee the internal audit functions for the company, ensuring compliance with regulatory requirements.

The appointment was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting commenced at 3:30 p.m. and concluded at 4:30 p.m. on the same day. The disclosure was submitted to the stock exchanges to inform shareholders and regulatory bodies.

H. Tara & Co. is registered with the Institute of Cost Accountants of India under Firm Registration No. 100265. The firm is led by CMA Harkesh Tara, a Cost Accountant and Registered Insolvency Professional. The firm confirmed that it holds a Certificate of Practice and operates independently at arm's length from the company.

Details of Appointment

The following table outlines the key details of the appointment as disclosed in the regulatory filing:

Sr. No.	Details of Events	Information
1.	Reason for appointment	Appointment for the Financial Year 2026-2027
2.	Date of appointment & term	Date: May 29, 2026. Term: Financial Year 2026-2027.
3.	Brief profile	CMA Harkesh Tara is a Cost Accountant and Registered Insolvency Professional specializing in Cost Accounting, Company Audit, Tax Audit, and Internal Audit.
4.	Disclosure of relationships	Not Applicable

The firm confirmed that it does not suffer from any disqualifications under the Companies Act, 2013, specifically relating to Section 138 regarding the appointment of an internal auditor. H. Tara & Co. also certified that there are no pending orders or proceedings against the firm or its partners before the Institute of Cost Accountants of India or any competent authority.